-
2024A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model., J Virol 2024 Apr; (): e0169323.
-
2022Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study., EBioMedicine 2022 Jan; 75(): 103810.
-
2021Discovery of genes that modulate flavivirus replication in an interferon-dependent manner, Journal of Molecular Biology, 2021, pp.167277. ⟨10.1016/j.jmb.2021.167277⟩.
-
2020Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models., Cell Host Microbe 2021 Feb 10;29(2):236-249: .
-
2018Differential regulation of the Wnt/β-catenin pathway by hepatitis C virus recombinants expressing core from various genotypes, Sci Rep 2018 Jul;8(1):11185.
-
2018Immature particles and capsid-free viral RNA produced by Yellow fever virus-infected cells stimulate plasmacytoid dendritic cells to secrete interferons., Sci Rep 2018 Jul; 8(1): 10889.
-
2018NS2 proteases from hepatitis C virus and related hepaciviruses share composite active sites and previously unrecognized intrinsic proteolytic activities, PLoS Pathog. 2018 02;14(2):e1006863.
-
2015Determinants Involved in Hepatitis C Virus and GB Virus B Primate Host Restriction, J. Virol. 2015 Dec;89(23):12131-44.
-
2015Functional expression, purification, characterization, and membrane reconstitution of non-structural protein 2 from hepatitis C virus, Protein Expr. Purif. 2015 Dec;116:1-6.
-
2014NS2 proteins of GB virus B and hepatitis C virus share common protease activities and membrane topologies, J. Virol. 2014 Jul;88(13):7426-44.
-
2010A comparative analysis of the substrate permissiveness of HCV and GBV-B NS3/4A proteases reveals genetic evidence for an interaction with NS4B protein during genome replication, Virology 2010 Oct;406(2):228-40.
-
2010The disulfide bonds in glycoprotein E2 of hepatitis C virus reveal the tertiary organization of the molecule, PLoS Pathog. 2010 Feb;6(2):e1000762.
-
2009Lack of adaptation of chimeric GB virus B/hepatitis C virus in the marmoset model: possible effects of bottleneck, J. Virol. 2009 Aug;83(16):8062-75.
-
2009A cooperative interaction between nontranslated RNA sequences and NS5A protein promotes in vivo fitness of a chimeric hepatitis C/GB virus B, PLoS ONE 2009;4(2):e4419.
-
2008A comparative cell biological analysis reveals only limited functional homology between the NS5A proteins of hepatitis C virus and GB virus B, J. Gen. Virol. 2008 Aug;89(Pt 8):1911-20.
-
2007Inhibition of hepatitis C virus infection in cell culture by small interfering RNAs, Mol. Ther. 2007 Aug;15(8):1452-62.
-
2006Core protein domains involved in hepatitis C virus-like particle assembly and budding at the endoplasmic reticulum membrane, Cell. Microbiol. 2007 Apr;9(4):1014-27.
-
2006GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS, J. Virol. 2007 Jan;81(2):964-76.
-
2006Signal peptide peptidase cleavage of GB virus B core protein is required for productive infection in vivo, J. Biol. Chem. 2006 Sep;281(39):29221-7.
-
2006Hepatitis A virus: from discovery to vaccines, Hepatology 2006 Feb;43(2 Suppl 1):S164-72.
-
2005A chimeric GB virus B with 5′ nontranslated RNA sequence from hepatitis C virus causes hepatitis in tamarins, Hepatology 2005 May;41(5):986-94.
-
2004Characterization of GB virus B polyprotein processing reveals the existence of a novel 13-kDa protein with partial homology to hepatitis C virus p7 protein, J. Biol. Chem. 2004 Jun;279(24):24965-75.
-
2003Chronic hepatitis associated with GB virus B persistence in a tamarin after intrahepatic inoculation of synthetic viral RNA, Proc. Natl. Acad. Sci. U.S.A. 2003 Aug;100(17):9962-7.
-
2002Analysis of deletion mutants indicates that the 2A polypeptide of hepatitis A virus participates in virion morphogenesis, J. Virol. 2002 Aug;76(15):7495-505.
-
2001Characterization of recombinant hepatitis A virus genomes containing exogenous sequences at the 2A/2B junction, J. Virol. 2001 Feb;75(3):1414-26.